Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 281
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02514694 | LEO 32731 - A Phase I Study in Healthy Subjects | ||
| NCT02935582 | PSOREAL - Managing PSOriasis in the REAL World | ||
| NCT05923099 | A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis | ||
| NCT04227288 | A Study Evaluating the Efficacy and Tolerability of Enstilar Foam in Patients With Nail Psoriasis | ||
| NCT02748902 | Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands. | ||
| NCT00051545 | Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma | ||
| NCT03080545 | Enstilar in Combination With Biologic Agents | ||
| NCT05099133 | A Trial to Evaluate Pharmacokinetics, Immunogenicity, Safety, and Tolerability of LEO 138559 in Healthy Japanese Subjects | ||
| NCT01836367 | Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp | ||
| NCT00186745 | Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure | ||
| NCT02219633 | Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD) | ||
| NCT01130025 | Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer | ||
| NCT01387711 | PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Histology | ||
| NCT04305327 | Efficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque Psoriasis | ||
| NCT00392067 | LEO19123 Cream in the Treatment of Atopic Dermatitis | ||
| NCT02124239 | Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use Conditions | ||
| NCT01257919 | Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosacea | ||
| NCT03812198 | A Trial to Investigate the Safety, Tolerability, and Drug Levels in Blood After Single and Multiple Doses of LEO 32731 in Healthy People | ||
| NCT01037881 | LEO 29102 Cream in the Treatment of Atopic Dermatitis | ||
| NCT06311682 | A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis | ||
| NCT02899962 | LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris | ||
| NCT04794569 | Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome | ||
| NCT01587755 | Optimising Outpatient Care in Mild to Moderate Psoriasis (PSO-TOP) | ||
| NCT00891709 | LEO 29102 Single and Multiple Dose Study by Dermal Application | ||
| NCT00225108 | The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean Section | ||
| NCT03331835 | A Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque Psoriasis | ||
| NCT01025635 | Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea | ||
| NCT01302925 | PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate Gel Followed by Hand Washing in Healthy Subjects | ||
| NCT03363854 | Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3 | ||
| NCT00403949 | A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis | ||
| NCT01947738 | Safety Study of VBY-891 in Healthy Volunteers After Single or Multiple (7 Days) of Oral Dosing (VBY891P1) | ||
| NCT00758862 | The Pharmacokinetics of 2% TD1414 Cream in Adults With Secondarily Infected Traumatic Lesions (SITL) or Impetigo | ||
| NCT05098821 | Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation | ||
| NCT01555463 | Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea | ||
| NCT01083758 | Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis | ||
| NCT03358914 | The PsoTeenQOL - Preliminary Reliability and Validity | ||
| NCT02424305 | Pharmacokinetics of LEO 43204 Gel in Actinic Keratosis Administered Under Maximal Use Conditions | ||
| NCT01998984 | Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis | ||
| NCT03126578 | Open-label, Single Center, Non-randomized, Fixed Sequence Phase 1 Drug-drug Interaction Study With LEO 32731 and Midazolam | ||
| NCT03114618 | A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient | ||
| NCT06773455 | Tralokinumab for Dupilumab Failures | ||
| NCT04853992 | Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic Urticaria | ||
| NCT02518048 | A Psoriasis Plaque Test Trial With LEO 90100 Compared to Betesil® in Patients With Psoriasis Vulgaris | ||
| NCT03806790 | Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris | ||
| NCT03193372 | A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated With Finacea Foam for Rosacea | ||
| NCT01007383 | LEO 27847 - A Study in Healthy Male Subjects | ||
| NCT01930396 | Use of Tinzaparin for Anticoagulation in Hemodialysis | ||
| NCT05682976 | Ophthalmological Adverse Events of Tralokinumab in AD | ||
| NCT02627989 | An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical Corticosteroids | ||
| NCT05355818 | Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand Eczema |
